US 11,986,232 B2
Systems and methods for improved treatment of headache
Brian Fahey, Menlo Park, CA (US); William Jason Fox, San Mateo, CA (US); Bryant Lin, Menlo Park, CA (US); and Vahid Saadat, Atherton, CA (US)
Assigned to Arrinex, Inc., Redwood City, CA (US)
Appl. No. 17/259,389
Filed by Arrinex, Inc., Redwood City, CA (US)
PCT Filed Jul. 22, 2019, PCT No. PCT/US2019/042877
§ 371(c)(1), (2) Date Jan. 11, 2021,
PCT Pub. No. WO2020/018999, PCT Pub. Date Jan. 23, 2020.
Claims priority of provisional application 62/743,471, filed on Oct. 9, 2018.
Claims priority of provisional application 62/701,379, filed on Jul. 20, 2018.
Prior Publication US 2021/0275241 A1, Sep. 9, 2021
Int. Cl. A61B 18/14 (2006.01); A61B 18/02 (2006.01); A61B 18/18 (2006.01); A61B 18/00 (2006.01)
CPC A61B 18/0218 (2013.01) [A61B 2018/00065 (2013.01); A61B 2018/00238 (2013.01); A61B 2018/00327 (2013.01); A61B 2018/00345 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00583 (2013.01); A61B 2018/0212 (2013.01); A61B 2018/0262 (2013.01)] 12 Claims
OG exemplary drawing
 
1. A method for treating or preventing a chronic daily headache, a cluster headache, a tension headache, a migraine, or an acute headache of a patient, the method comprising:
advancing a non-penetrating cryotherapy element into a nasal cavity of a patient with the cryotherapy element in a first collapsed configuration;
contacting the cryotherapy element with a surface of a nasal cavity tissue without penetrating the surface of the nasal cavity tissue;
reconfiguring the cryotherapy element from the first collapsed configuration to a second expanded configuration; and
cryogenically cooling a target treatment site with the cryotherapy element in order to treat or prevent a chronic daily headache, a cluster headache, a tension headache, a migraine, or an acute headache, wherein the target treatment site comprises a nerve branch originating from a trigeminal nerve.